70 related articles for article (PubMed ID: 1629111)
21. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
22. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
23. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
Smith HO; Tiffany MF; Qualls CR; Key CR
Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
[TBL] [Abstract][Full Text] [Related]
24. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.
Lea JS; Sheets EE; Wenham RM; Duska LR; Coleman RL; Miller DS; Schorge JO
Gynecol Oncol; 2002 Jan; 84(1):115-9. PubMed ID: 11748986
[TBL] [Abstract][Full Text] [Related]
25. The influence of patients age, type of tumor growth, hematocrit, and radiation-induced tumor regression on the prognosis of advanced uterine cervix carcinoma.
Boljesíková E; Gyárfásová M; Durkovský J
Neoplasma; 1988; 35(4):435-41. PubMed ID: 3185840
[TBL] [Abstract][Full Text] [Related]
26. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
Sherman ME; Wang SS; Carreon J; Devesa SS
Cancer; 2005 Mar; 103(6):1258-64. PubMed ID: 15693030
[TBL] [Abstract][Full Text] [Related]
27. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre MR
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):215-23. PubMed ID: 17125903
[TBL] [Abstract][Full Text] [Related]
28. Relation of histologic factors to the response of stage I epidermoid carcinoma of the cervix to surgical treatment. Analysis of 115 patients.
Sidhu GS; Koss LG; Barber RK
Obstet Gynecol; 1970 Mar; 35(3):329-38. PubMed ID: 5416699
[No Abstract] [Full Text] [Related]
29. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix.
Chen J; Macdonald OK; Gaffney DK
Obstet Gynecol; 2008 Jun; 111(6):1394-402. PubMed ID: 18515524
[TBL] [Abstract][Full Text] [Related]
30. Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma.
Schlenger K; Höckel M; Mitze M; Schäffer U; Weikel W; Knapstein PG; Lambert A
Gynecol Oncol; 1995 Oct; 59(1):57-66. PubMed ID: 7557616
[TBL] [Abstract][Full Text] [Related]
31. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
[TBL] [Abstract][Full Text] [Related]
32. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
33. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients.
Matthews CM; Burke TW; Tornos C; Eifel PJ; Atkinson EN; Stringer CA; Morris M; Silva EG
Gynecol Oncol; 1993 Apr; 49(1):19-23. PubMed ID: 8482554
[TBL] [Abstract][Full Text] [Related]
34. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma.
Eifel PJ; Burke TW; Morris M; Smith TL
Gynecol Oncol; 1995 Oct; 59(1):38-44. PubMed ID: 7557613
[TBL] [Abstract][Full Text] [Related]
35. [The integrated score of prognostic factors with regard to the recurrence of cervical carcinoma].
Kubota S; Okumura T; Ohara K; Akisada M; Gomi H; Nakano T; Arai T
Gan No Rinsho; 1987 Aug; 33(9):1061-4. PubMed ID: 3626033
[TBL] [Abstract][Full Text] [Related]
36. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
[TBL] [Abstract][Full Text] [Related]
37. Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma--clinicopathologic correlation.
Davidson B; Goldberg I; Gotlieb WH; Lerner-Geva L; Ben-Baruch G; Agulansky L; Novikov I; Kopolovic J
Acta Obstet Gynecol Scand; 1999 Mar; 78(3):240-4. PubMed ID: 10078587
[TBL] [Abstract][Full Text] [Related]
38. Histopathological studies of carcinoma of cervix uteri in Ibadan.
Adelusi B; Smith JA; Junaid TA
Afr J Med Med Sci; 1978 Mar; 7(1):9-16. PubMed ID: 97956
[TBL] [Abstract][Full Text] [Related]
39. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among Tunisian women.
Missaoui N; Trabelsi A; Landolsi H; Jaidaine L; Mokni M; Korbi S; Hmissa S
Asian Pac J Cancer Prev; 2010; 11(3):777-80. PubMed ID: 21039053
[TBL] [Abstract][Full Text] [Related]
40. Youth as a prognostic factor in carcinoma of the cervix: a matched analysis.
Rutledge FN; Mitchell MF; Munsell M; Bass S; McGuffee V; Atkinson EN
Gynecol Oncol; 1992 Feb; 44(2):123-30. PubMed ID: 1544591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
